Post-operative radioactive iodine administration in patients with low-risk thyroid cancer

Radioactive iodine (RAI) treatment is used in patients with thyroid cancer to treat disease and to eradicate normal thyroid remnants. Routine post-operative administration of RAI is no longer indicated in patients with low risk thyroid cancer and might instead be used selectively in patients with a post-operative high serum level of thyroglobulin.

Automated summary

RAI treatment is used in thyroid cancer patients for disease treatment and removal of normal thyroid remnants. Routine post-operative administration of RAI is no longer recommended in low risk thyroid cancer patients.